Premier Urges House Committee to Address Critical Healthcare Supply Chain Issues
Premier submitted a statement for a June 11, 2025 House Energy and Commerce Health Subcommittee hearing entitled “Made in America: Strengthening Domestic Manufacturing and Our Health Care Supply Chain.” In its statement, Premier underscored that securing our nation’s healthcare supply chain has been a long-standing priority for Premier from both a policy perspective and market-based approach. As the subcommittee considers policy reforms to address critical healthcare supply chain issues, Premier urged the Subcommittee to consider:
Leveraging tax credits as a mechanism to incentivize manufacturers to invest in domestic production while also ensuring that domestically manufactured goods are price competitive with globally sourced products.
Taking action to strengthen domestic manufacturing of essential medicines by:
Requiring federal agencies to purchase domestically manufactured medical supplies when available;
Providing CMS with statutory authority to implement payment adjustments for domestically manufactured critical medical supplies and pharmaceuticals in a non-budget neutral manner; and
Adapting the Food and Drug Administration (FDA) regulatory framework for approval to expedite review of applications and inspections of manufacturing facilities for new domestic entrants.
Passing the bipartisan and bicameral Medical Supply Chain Resiliency Act (S. 998/H.R. 2213) to establish trade agreements with trusted trade partner countries to diversify sourcing for critical medical devices and pharmaceuticals, protect public health and bolster national security.
